Taiho Oncology, Inc.
Ed Chapman has extensive work experience in the IT field. Ed started their career in 1989 at EDS as an Advanced SE. Ed then worked at Noblestar for nearly a decade as a Division Director. After that, they became a Principal at Integration Point Solutions. Ed joined Celgene in 2005 and held various roles such as Associate Director, Director of Global Applications Development, and Global Head of IT Business Partnership. In 2012, they joined Immunomedics as a Senior Director of IT. Currently, they are the Chief Information Officer at TAIHO ONCOLOGY INC.
Ed Chapman has a Bachelor of Science degree in Management Information Systems and Accounting from California State University, Chico. Ed also holds additional certifications in "Artificial Intelligence: Implications for Business Strategy" from MIT Sloan School of Management, obtained in April 2020, and "Project Management Professional (PMP)" from PMI, with no specific information regarding the date of completion.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com